PreEmptive Meds, Pvt. Ltd Report issue

For profit Phase 3
Founded: KOTTAYAM India (2011)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2013
NCT02189005
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Joe Fenn

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 3)

Glucose Intolerance (Phase 3)

Hyperglycemia (Phase 3)

Metabolic Syndrome (Phase 3)

Prediabetic State (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 5